Publications by authors named "Scott Kopetz"

100Publications

Circulating tumor DNA as a marker of minimal residual disease in colorectal cancer.

Authors:
Scott Kopetz

Clin Adv Hematol Oncol 2020 Dec;18(12):791-792

Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article and Find Full Text PDF
December 2020

Alteration of FBXW7 is Associated with Worse Survival in Patients Undergoing Resection of Colorectal Liver Metastases.

J Gastrointest Surg 2020 Nov 17. Epub 2020 Nov 17.

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1484, Houston, TX, 77030, USA.

View Article and Find Full Text PDF
November 2020

Tumor Sidedness, Recurrence, and Survival After Curative Resection of Localized Colon Cancer.

Clin Colorectal Cancer 2020 Aug 31. Epub 2020 Aug 31.

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article and Find Full Text PDF
August 2020

Applying Precision to the Management of BRAF-Mutant Metastatic Colorectal Cancer.

Target Oncol 2020 Oct;15(5):567-577

Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 426, Houston, TX, 77030, USA.

View Article and Find Full Text PDF
October 2020

Reply to S. Boutayeb et al.

JCO Oncol Pract 2020 Aug 23;16(8):525. Epub 2020 Jun 23.

Emil Lou, MD, PhD, Masonic Cancer Center, University of Minnesota, Minneapolis, MN; Muhammad Shaalan Beg, MD, University of Texas Southwestern Medical Center, Dallas, TX; Emily Bergsland, MD, University of California San Francisco, San Francisco, CA; Cathy Eng, MD, Vanderbilt-Ingram Cancer Center, Nashville, TN; Alok A. Khorana, MD, Cleveland Clinic, Cleveland, OH; Scott Kopetz, MD, PhD, University of Texas MD Anderson Cancer Center, Houston, TX; Sam Lubner, MD, University of Wisconsin, Madison, WI; Leonard Saltz, MD, Memorial Sloan Kettering Cancer Center, New York, NY; Veena Shankaran, MD, MS, University of Washington, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle, WA; and S. Yousuf Zafar, MD, MHS, Duke Cancer Institute, Durham, NC.

View Article and Find Full Text PDF
August 2020

Relative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract.

Genes (Basel) 2020 06 11;11(6). Epub 2020 Jun 11.

Sheikh Ahmed Center for Pancreatic Cancer Research and the Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article and Find Full Text PDF
June 2020

Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer.

Cell Death Dis 2020 05 11;11(5):346. Epub 2020 May 11.

Department of General Surgery and Center of Minimal Invasive Gastrointestinal Surgery, The First Hospital Affiliated to Army Medical University, Chongqing, China.

View Article and Find Full Text PDF
May 2020

Liquid biopsy, a paradigm shift in oncology: what interventional radiologists should know.

Eur Radiol 2020 Aug 19;30(8):4496-4503. Epub 2020 Mar 19.

Department of Interventional Radiology, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA.

View Article and Find Full Text PDF
August 2020

Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer. Reply.

N Engl J Med 2020 02;382(9):877-878

Vall d'Hebron Institute of Oncology, Barcelona, Spain

View Article and Find Full Text PDF
February 2020

Colon Cancer in Patients Under 25 Years Old: A Different Disease?

J Am Coll Surg 2020 04 21;230(4):648-656. Epub 2020 Feb 21.

University of Texas, MD Anderson Cancer Center, Houston TX.

View Article and Find Full Text PDF
April 2020

Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility.

Gut 2020 04 7;69(4):748-763. Epub 2020 Feb 7.

Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

View Article and Find Full Text PDF
April 2020

The BE GONE trial study protocol: a randomized crossover dietary intervention of dry beans targeting the gut microbiome of overweight and obese patients with a history of colorectal polyps or cancer.

BMC Cancer 2019 Dec 18;19(1):1233. Epub 2019 Dec 18.

Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1340, Houston, TX, TX 77030, USA.

View Article and Find Full Text PDF
December 2019

Is the Patient Cured?

JAMA Oncol 2019 Oct 17. Epub 2019 Oct 17.

Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston.

View Article and Find Full Text PDF
October 2019

Encorafenib, Binimetinib, and Cetuximab in V600E-Mutated Colorectal Cancer.

N Engl J Med 2019 10 30;381(17):1632-1643. Epub 2019 Sep 30.

From the University of Texas M.D. Anderson Cancer Center, Houston (S.K., V.M.); West Cancer Center and Research Institute, OneOncology, Germantown, TN (A. Grothey); Memorial Sloan Kettering Cancer Center, New York (R.Y., A.K.); University Hospital Gasthuisberg and University of Leuven, Leuven, Belgium (E.V.C., J. Dekervel); the Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (J. Desai, C.G.); National Cancer Center Hospital East, Kashiwa, Japan (T.Y.); Hammersmith Hospital, Division of Cancer, Imperial College London (H.W.), and the Sarah Cannon Research Institute and University College London Cancer Institute (H.-T.A.), London, and the Christie NHS Foundation Trust/National Institute for Health Research Manchester Biomedical Research Centre, Manchester (M.B.) - all in the United Kingdom; the University of Campania Luigi Vanvitelli, Naples (F.C.), and Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua (F.L., S.L.) - both in Italy; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (Y.S.H., T.-W.K.); the Netherlands Cancer Institute, Amsterdam (N.S., J.H.M.S.); Oslo University Hospital, Oslo (T.K.G.); Hospital Gregorio Marañón, Madrid (P.G.-A., A.C.F.), and Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, UVic, IOB-Quiron, Barcelona (E.E., J.T.) - both in Spain; Odense University Hospital, Odense, Denmark (P.P., L.S.T.); Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia (S.O.); and Array BioPharma, Boulder, CO (A. Gollerkeri, C.K., K.M., M.P., J.C.-B., L.A., V.S.).

View Article and Find Full Text PDF
October 2019

Current and Future Horizons of Patient-Derived Xenograft Models in Colorectal Cancer Translational Research.

Cancers (Basel) 2019 Sep 6;11(9). Epub 2019 Sep 6.

Department of Genomic Medicine, UT MD Anderson cancer center, Houston, TX 77054, USA.

View Article and Find Full Text PDF
September 2019

Non-invasive genotyping of metastatic colorectal cancer using circulating cell free DNA.

Cancer Genet 2019 09 12;237:82-89. Epub 2019 Jun 12.

Department of Translational Molecular Pathology, Division of Pathology and Laboratory Medicine, The University of Texas M.D. Anderson Cancer Center, 6565 MD Anderson Blvd., Houston, TX 77030, United States; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States. Electronic address:

View Article and Find Full Text PDF
September 2019

Development and Application of Duplex Sequencing Strategy for Cell-Free DNA-Based Longitudinal Monitoring of Stage IV Colorectal Cancer.

J Mol Diagn 2019 11 8;21(6):994-1009. Epub 2019 Aug 8.

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article and Find Full Text PDF
November 2019

CTC analysis: an update on technological progress.

Transl Res 2019 10 11;212:14-25. Epub 2019 Jul 11.

Department of Pediatrics - Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article and Find Full Text PDF
October 2019

Genetic profiling as a clinical tool in advanced parathyroid carcinoma.

J Cancer Res Clin Oncol 2019 Aug 15;145(8):1977-1986. Epub 2019 Jul 15.

Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street Unit 1461, Houston, TX, 77030, USA.

View Article and Find Full Text PDF
August 2019

Biomarker-guided therapy for colorectal cancer: strength in complexity.

Nat Rev Clin Oncol 2020 01 9;17(1):11-32. Epub 2019 Jul 9.

Department of Molecular Oncology, Institute for Cancer Research & K.G. Jebsen Colorectal Cancer Research Centre, Division for Cancer Medicine, Oslo University Hospital, Oslo, Norway.

View Article and Find Full Text PDF
January 2020

Mechanisms of Innate and Acquired Resistance to Anti-EGFR Therapy: A Review of Current Knowledge with a Focus on Rechallenge Therapies.

Clin Cancer Res 2019 12 1;25(23):6899-6908. Epub 2019 Jul 1.

Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article and Find Full Text PDF
December 2019

Can Circulating Tumor DNA in Early-Stage Colorectal Cancer Be More Than a Prognostic Biomarker?

JAMA Oncol 2019 May 9. Epub 2019 May 9.

The University of Texas MD Anderson Cancer Center, Houston.

View Article and Find Full Text PDF
May 2019

Conditional Recurrence-Free Survival after Resection of Colorectal Liver Metastases: Persistent Deleterious Association with RAS and TP53 Co-Mutation.

J Am Coll Surg 2019 09 2;229(3):286-294.e1. Epub 2019 May 2.

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article and Find Full Text PDF
September 2019

Ongoing and future directions in the management of metastatic colorectal cancer: Update on clinical trials.

J Surg Oncol 2019 Apr 10;119(5):642-652. Epub 2019 Mar 10.

Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article and Find Full Text PDF
April 2019

Back to the Colorectal Cancer Consensus Molecular Subtype Future.

Curr Gastroenterol Rep 2019 Jan 30;21(2). Epub 2019 Jan 30.

Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard--Unit 0426, Houston, TX, 77030, USA.

View Article and Find Full Text PDF
January 2019

New therapies and insights into the changing landscape of colorectal cancer.

Authors:
Scott Kopetz

Nat Rev Gastroenterol Hepatol 2019 02;16(2):79-80

University of Texas, MD Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF
February 2019

Circulating Tumor DNA-Defined Minimal Residual Disease in Solid Tumors: Opportunities to Accelerate the Development of Adjuvant Therapies.

J Clin Oncol 2018 Oct 30:JCO2018789032. Epub 2018 Oct 30.

Arvind Dasari, The University of Texas MD Anderson Cancer Center, Houston, TX; Axel Grothey, The University of Tennessee West Cancer Center, Memphis, TN; and Scott Kopetz, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article and Find Full Text PDF
October 2018

Bioactive lipid metabolism in platelet "first responder" and cancer biology.

Cancer Metastasis Rev 2018 09;37(2-3):439-454

Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.

View Article and Find Full Text PDF
September 2018

Phase II study of DFP-10917, a deoxycytidine analog, given by 14-day continuous intravenous infusion for chemotherapy-refractory advanced colorectal cancer.

Invest New Drugs 2018 10 13;36(5):895-902. Epub 2018 Jun 13.

Department of Gastrointestinal Medical Oncology, Unit 426, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.

View Article and Find Full Text PDF
October 2018

How should BRAF V600E-mutated colorectal cancer be treated?

Authors:
Scott Kopetz

Clin Adv Hematol Oncol 2018 May;16(5):333-335

The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article and Find Full Text PDF
May 2018

Platelet Metabolism and Other Targeted Drugs; Potential Impact on Immunotherapy.

Front Oncol 2018 20;8:107. Epub 2018 Apr 20.

Department of GI Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

View Article and Find Full Text PDF
April 2018

Untying the gordion knot of targeting MET in cancer.

Cancer Treat Rev 2018 May 26;66:95-103. Epub 2018 Apr 26.

Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic address:

View Article and Find Full Text PDF
May 2018

Correction to: Accelerating Therapeutic Development through Innovative Trial Design in Colorectal Cancer.

Curr Treat Options Oncol 2018 04 23;19(5):25. Epub 2018 Apr 23.

Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard-Unit 0426, Houston, TX, 77030, USA.

View Article and Find Full Text PDF
April 2018

Two phase I, pharmacokinetic, and pharmacodynamic studies of DFP-10917, a novel nucleoside analog with 14-day and 7-day continuous infusion schedules.

Invest New Drugs 2019 02 18;37(1):76-86. Epub 2018 Apr 18.

Department of Gastrointestinal Medical Oncology, Unit 426, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.

View Article and Find Full Text PDF
February 2019

SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases.

Eur J Surg Oncol 2018 05 7;44(5):684-692. Epub 2018 Mar 7.

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article and Find Full Text PDF
May 2018

Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer.

Clin Cancer Res 2018 08 7;24(16):3867-3877. Epub 2018 Mar 7.

Center for Gastrointestinal Research, Center for Translational Genomics and Oncology, Baylor Scott & White Research Institute and Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas.

View Article and Find Full Text PDF
August 2018

Accelerating Therapeutic Development through Innovative Trial Design in Colorectal Cancer.

Curr Treat Options Oncol 2018 02 27;19(2):11. Epub 2018 Feb 27.

Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard-Unit 0426, Houston, TX, 77030, USA.

View Article and Find Full Text PDF
February 2018

Nivolumab in the treatment of microsatellite instability high metastatic colorectal cancer.

Future Oncol 2018 08 23;14(18):1869-1874. Epub 2018 Feb 23.

Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1400 Holcombe Blvd, Houston, TX 77030, USA.

View Article and Find Full Text PDF
August 2018

Impact of Prior Hepatectomy History on Local Tumor Progression after Percutaneous Ablation of Colorectal Liver Metastases.

J Vasc Interv Radiol 2018 03 1;29(3):395-403.e1. Epub 2018 Feb 1.

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1400 Pressler St., Unit 1471, Houston, TX 77030.

View Article and Find Full Text PDF
March 2018

Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer.

J Clin Oncol 2018 03 20;36(8):773-779. Epub 2018 Jan 20.

Michael J. Overman and Scott Kopetz, University of Texas MD Anderson Cancer Center, Houston, TX; Sara Lonardi, Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padova; Fabio Gelsomino, University Hospital of Modena, Modena; Massimo Aglietta, Institute for Cancer Research and Treatment of Candiolo, University of Torino Medical School, Turin, Italy; Ka Yeung Mark Wong, Sydney Medical School, University of Sydney, Sydney, New South Wales; Andrew Hill, Tasman Oncology Research, Ltd., Southport, Queensland, Australia; Heinz-Josef Lenz, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA; Michael A. Morse, Duke University Medical Center, Durham, NC; Eric Van Cutsem, University Hospitals Gasthuisberg Leuven and Katholieke Universiteit Leuven, Leuven; Alain Hendlisz, Institut Jules Bordet; Bart Neyns, Universitair Ziekenhuis Brussel, Brussels; Jean-Marie Ledeine, Bristol-Myers Squibb, Braine-L'Alleud, Belgium; Ray McDermott, St Vincent's University Hospital and Cancer Trials Ireland, Dublin, Ireland; Michael B. Sawyer, Cross Cancer Institute and University of Alberta, Edmonton, Alberta, Canada; Magali Svrcek and Thierry André, Hopital Saint Antoine, Assistance Publique Hôpitaux de Paris and Sorbonne Universités, Université Pierre et Marie Curie, Paris, France; and Rebecca A. Moss, Z. Alexander Cao, and Shital Kamble, Bristol-Myers Squibb, Princeton, NJ.

View Article and Find Full Text PDF
March 2018

Arginine methylation of EGFR: a new biomarker for predicting resistance to anti-EGFR treatment.

Am J Cancer Res 2017 1;7(12):2587-2599. Epub 2017 Dec 1.

Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer CenterTX 77030, Houston, USA.

View Article and Find Full Text PDF
December 2017